Brief: FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD

Cingulate

21/05/2024 14:04

May 21 (Reuters) - Cingulate Inc  CING.O :
    * FDA CLEARS CINGULATE TO FILE FOR MARKETING APPROVAL OF
CTX-1301
IN THE TREATMENT OF ADHD
    * CINGULATE INC: ADVANCING DISCUSSIONS WITH
COMMERCIALIZATION
PARTNERS
    * CINGULATE INC: CINGULATE HAS BEGUN NDA PREPARATION AND
EXPECTS
TO SUBMIT ITS FILING IN FIRST HALF OF 2025

Source text for Eikon:  ID:nGNX4hM6fG 
Further company coverage:  CING.O 

 ((Reuters.Briefs@thomsonreuters.com;))